Dexcom : Reports Preliminary, Unaudited Revenue for the Fourth Quarter 2021 and Summary Data from the Dexcom G7 U.S. Pivotal Trial - Form 8-K
DexCom, Inc. , the leader in real-time continuous glucose monitoring , today reported that it expects preliminary, unaudited revenue for the fourth quarter ended December 31, 2021 to be approximately... | January 10, 2022
Source: marketscreener.com